These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19578081)

  • 1. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections.
    Traunmüller F; Schintler MV; Metzler J; Spendel S; Mauric O; Popovic M; Konz KH; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2010 Jun; 65(6):1252-7. PubMed ID: 20375031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular concentrations of fosfomycin in lung tissue of septic patients.
    Matzi V; Lindenmann J; Porubsky C; Kugler SA; Maier A; Dittrich P; Smolle-Jüttner FM; Joukhadar C
    J Antimicrob Chemother; 2010 May; 65(5):995-8. PubMed ID: 20228081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
    Traunmüller F; Schintler MV; Spendel S; Popovic M; Mauric O; Scharnagl E; Joukhadar C
    Int J Antimicrob Agents; 2010 Jul; 36(1):84-6. PubMed ID: 20456925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target site penetration of fosfomycin in critically ill patients.
    Joukhadar C; Klein N; Dittrich P; Zeitlinger M; Geppert A; Skhirtladze K; Frossard M; Heinz G; Müller M
    J Antimicrob Chemother; 2003 May; 51(5):1247-52. PubMed ID: 12668580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
    Lipsky BA; Stoutenburgh U
    J Antimicrob Chemother; 2005 Feb; 55(2):240-5. PubMed ID: 15659542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
    Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams].
    Lebreton P; Vergnaud M; Zerr C; Nigam M; Kaladji C; Quesnel J
    Cah Anesthesiol; 1989; 37(2):77-87. PubMed ID: 2731058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
    Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH
    J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
    Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
    J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
    Pfausler B; Spiss H; Dittrich P; Zeitlinger M; Schmutzhard E; Joukhadar C
    J Antimicrob Chemother; 2004 May; 53(5):848-52. PubMed ID: 15056646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common pathogens isolated in diabetic foot infection in Bir Hospital.
    Sharma VK; Khadka PB; Joshi A; Sharma R
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):295-301. PubMed ID: 18603922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers.
    Galkowska H; Podbielska A; Olszewski WL; Stelmach E; Luczak M; Rosinski G; Karnafel W
    Diabetes Res Clin Pract; 2009 May; 84(2):187-93. PubMed ID: 19269053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis.
    Kessler L; Piemont Y; Ortega F; Lesens O; Boeri C; Averous C; Meyer R; Hansmann Y; Christmann D; Gaudias J; Pinget M
    Diabet Med; 2006 Jan; 23(1):99-102. PubMed ID: 16409574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
    Stein GE; Throckmorton JK; Scharmen AE; Weiss WJ; Prokai L; Smith CL; Havlichek DH
    J Antimicrob Chemother; 2013 Dec; 68(12):2852-8. PubMed ID: 23873647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.